Delivery Order SPE2DB24D2213-SPE2DB25FGWJS

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,103.96, is for the delivery of REPATHA 140 MG/ML SURECLICK syringes. It is a firm fixed-price delivery order contract with a period of performance through January 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor on...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,396.63, is for the delivery of REPATHA 140 MG/ML SURECLICK syringes. The contract has an ultimate completion date of January 9, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,402.64 firm fixed price delivery order is for the product "REPATHA 140 MG/ML SURECLICKML" and has a completion date of February 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,316.85, is for the supply of REPATHA 140 MG/ML SURECLICK syringes. The contract has a completion date of February 14, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,103.96 Firm Fixed Price Delivery Order is for the supply of REPATHA 140 MG/ML SURECLICK syringes. The contract has an ultimate completion date of March 25, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,940.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of November 5, 2024, is a delivery order for the product "REPATHA 140 MG/ML SURECLICKML." The contract is a firm fixed-price arrangement, with no set-aside designation. Amerisourcebergen, a for-profit organization registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,402.64 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICK, a specialty medication. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.70 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.77 firm fixed-price delivery order is for REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award is a Delivery Order valued at $3,277.96 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of REPATHA 140 MG/ML SURECLICKML, a medication, with a completion date of November 22, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery...
  • SPE2DB24D2213
    Indefinite Delivery Contract
  • SPE2DB24D2213-SPE2DB25FGWJS
    Delivery Order

This federal contract award, valued at $1,402.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICK syringes, with an ultimate completion date of April 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/8/25, 2:24 PM